Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#Hematocrit Test Devices Market Size Outlook: How Quickly Will Revenue Expand Through 2030?#_x000D_
The hematocrit test devices market size has experienced strong growth in recent years. It is projected to expand from $4.91 billion in 2025 to $5.22 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.4%. The historical growth in this market can be attributed to several factors, including the increasing prevalence of anemia and blood disorders, a rise in hospital and laboratory diagnostic testing, growing demand for blood donor screening, the expansion of emergency and trauma care services, and an increasing awareness of hematocrit monitoring in clinical practice._x000D_
_x000D_
The hematocrit test devices market is projected to experience robust expansion over the coming years. It is anticipated to reach a valuation of $6.47 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.5%. This growth during the forecast period can be primarily ascribed to an escalating demand for point-of-care diagnostic solutions, a growing prevalence of chronic and lifestyle-related illnesses, the expansion of decentralized healthcare systems and at-home testing options, increasing capital allocation towards diagnostic infrastructure, and a heightened emphasis on early disease identification and preventative health measures. Key trends anticipated during this period encompass a surge in the adoption of point-of-care hematocrit testing devices, an increasing need for prompt and precise blood parameter evaluations, wider utilization of portable and handheld hematocrit meters, the broadening application of hematocrit testing within emergency and critical care environments, and a greater emphasis on routine health screenings and the management of chronic conditions._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Hematocrit Test Devices Market Growth Drivers: What’s Behind The Acceleration?#_x000D_
The increasing incidence of blood disorders is anticipated to stimulate the expansion of the hematocrit test devices market moving forward. A blood disorder is characterized as a condition impacting components of human blood, including red blood cells, white blood cells, platelets, and blood plasma. The rising occurrence of these disorders is linked to various factors such as genetic predispositions, environmental pollution, and changes in lifestyle. Hematocrit test devices primarily serve to quantify the volume percentage of red blood cells within whole blood, thereby offering vital data concerning a patient’s hematological well-being. Illustratively, in January 2024, a report by the American Cancer Society, a US-based non-profit organization, projected around 62,770 new cases of leukemia across all types in the United States for 2024, leading to an estimated 23,670 deaths. Among these, approximately 20,800 new instances of acute myeloid leukemia (AML) are expected, predominantly affecting adults, with about 11,220 deaths attributed to AML, almost exclusively among adult patients. Therefore, the growing number of blood disorder cases is propelling the growth of the hematocrit test devices market._x000D_
_x000D_
#Hematocrit Test Devices Market Segment Analysis Spotlighting Growth Areas#_x000D_
The hematocrit test devices market covered in this report is segmented – _x000D_
_x000D_
1) By Product: Hematocrit Test Meter, Hematocrit Test Analyzer, Reagents And Consumables_x000D_
2) By Application: Anemia, Polycythemia Vera, Congenital Heart Diseases, Other Applications_x000D_
3) By End-User: Hospitals And Ambulatory Surgical Centers, Clinics, Diagnostic And Pathology Labs, Other End-Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Hematocrit Test Meter: Handheld Hematocrit Meters, Portable Hematocrit Meters, Desktop Hematocrit Meters, Point-Of-Care Hematocrit Meters, Digital Hematocrit Meters, Battery-Powered Hematocrit Meters _x000D_
2) By Hematocrit Test Analyzer: Automated Hematocrit Analyzers, Benchtop Hematocrit Analyzers, Semi-Automated Hematocrit Analyzers, Microhematocrit Analyzers, High-Throughput Hematocrit Analyzers, Compact Hematocrit Analyzers _x000D_
3) By Reagents And Consumables: Hematocrit Test Strips, Hematocrit Pipettes And Capillaries, Blood Sample Collection Tubes For Hematocrit Testing, Quality Control Reagents For Hematocrit Testing, Calibration Standards For Hematocrit Devices, Disposable Test Kits And Consumables_x000D_
_x000D_
#Hematocrit Test Devices Market Trends: What’s Defining The Industry’s Next Phase?#_x000D_
Leading companies within the hematocrit test device sector are prioritizing sophisticated technologies, specifically user-friendly platforms tailored for laboratories with medium testing volumes. Such platforms are systems incorporating intuitive, simple-to-use features, allowing for rapid operation with very little training required. As an illustration, in March 2024, Mindray, a health technology firm based in China, launched the BC-700 Series—a streamlined, integrated hematology analyzer designed for small to medium laboratories, which merges CBC and ESR testing capabilities into a single unit. This device yields results in merely 1.5 minutes, significantly enhancing both efficiency and workflow. The system employs SF Cube 3D analysis technology to achieve precise cell differentiation and incorporates the PLT-H parameter to enhance platelet counting accuracy. Its integration of CBC and ESR into one instrument leads to a reduction in both equipment and consumable expenses. Offered in both open vial and autoloader configurations, the BC-700 Series offers dependable, automated, and compact testing solutions, demonstrating a strong alignment with conventional methods while also improving safety and repeatability._x000D_
_x000D_
#Hematocrit Test Devices Market Leading Companies And Competitive Benchmarking#_x000D_
Major companies operating in the hematocrit test devices market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton Dickinson and Company, Terumo Corporation, Beckman Coulter Inc., Mindray Medical International Limited, bioMérieux SA, Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Erba Mannheim, EKF Diagnostics Holding Plc., Nova Biomedical Corporation, Boule Diagnostics AB, Stanbio Laboratory LP, Drucker Diagnostics, A. Menarini Diagnostics Srl, Sensa Core, Mikroscan Technologies Inc. _x000D_
_x000D_
#View The Full Hematocrit Test Devices Market Report:#_x000D_
_x000D_
#Hematocrit Test Devices Market Top Region By Revenue And Market Share#_x000D_
North America was the largest region in the hematocrit test devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hematocrit test devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.